Literature DB >> 27920248

Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change.

Nicole L Pratt1, Lisa M Kalisch Ellett1, Janet K Sluggett2, Svetla V Gadzhanova1, Emmae N Ramsay1, Mhairi Kerr1, Vanessa T LeBlanc1, John D Barratt1, Elizabeth E Roughead1.   

Abstract

OBJECTIVE: To evaluate the impact of national multifaceted initiatives to improve use of proton pump inhibitors (PPIs) on the use of PPIs among older Australians.
DESIGN: Interrupted time series analysis using administrative health claims data from the Australian Government Department of Veterans' Affairs (DVA).
SETTING: Australia. PARTICIPANTS: All veterans and dependents who received PPIs between January 2003 and December 2013. INTERVENTION(S): National, multifaceted interventions to improve PPI use were conducted by the Australian Government Department of Veterans' Affairs Veterans' MATES programme and Australia's NPS MedicineWise in April 2004, June 2006, May 2009 and August 2012. MAIN OUTCOME MEASURE(S): Trends in monthly rate of use of any PPI among the veteran population, and the monthly rate of use of low strength PPIs among all veterans dispensed a PPI.
RESULTS: Interventions in 2004, 2006, 2009 and 2012 slowed the rate of increase in PPI use significantly, with the 2012 intervention resulting in a sustained 0.04% decrease in PPI use each month. The combined effect of all four interventions was a 20.9% (95% CI 7.8-33.9%) relative decrease in PPI use 12 months after the final intervention. The four interventions also resulted in a 42.2% (95% CI 19.9-64.5%) relative increase in low strength PPI use 12 months after the final intervention.
CONCLUSIONS: National multifaceted programmes targeting clinicians and consumers were effective in reducing overall PPI use and increasing use of low strength PPIs. Interventions to improve PPI use should incorporate regular repetition of key messages to sustain practice change.
© The Author 2016. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  Australia; aged; drug utilization; proton pump inhibitors; quality improvement

Mesh:

Substances:

Year:  2017        PMID: 27920248     DOI: 10.1093/intqhc/mzw138

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  13 in total

Review 1.  Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.

Authors:  Tom D Wilsdon; Ivanka Hendrix; Tilenka R J Thynne; Arduino A Mangoni
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 2.  Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review.

Authors:  Jérôme Nguyen-Soenen; Cédric Rat; Jean-Pascal Fournier
Journal:  Eur J Clin Pharmacol       Date:  2019-11-06       Impact factor: 2.953

3.  Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case-Control Study.

Authors:  Kate N Wang; J Simon Bell; Edwin C K Tan; Julia F M Gilmartin-Thomas; Michael J Dooley; Jenni Ilomäki
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

4.  Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.

Authors:  Jianyun Wu; Scott Dickinson; Zain Elgebaly; Suzanne Blogg; Aine Heaney; Yien Soo; Benjamin Daniels; Lynn Weekes
Journal:  BMC Fam Pract       Date:  2020-05-09       Impact factor: 2.497

5.  Health professionals' and researchers' opinions on conducting clinical deprescribing trials.

Authors:  Alexander J Clough; Sarah N Hilmer; Lisa Kouladjian-O'Donnell; Sharon L Naismith; Danijela Gnjidic
Journal:  Pharmacol Res Perspect       Date:  2019-04-25

6.  Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents.

Authors:  Lisa M Kalisch Ellett; Gizat M Kassie; Nicole L Pratt; Mhairi Kerr; Elizabeth E Roughead
Journal:  Pharmacy (Basel)       Date:  2019-06-06

7.  Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia.

Authors:  Claudia Bruno; Sallie-Anne Pearson; Benjamin Daniels; Nicholas A Buckley; Andrea Schaffer; Helga Zoega
Journal:  BMJ Qual Saf       Date:  2019-10-22       Impact factor: 7.035

Review 8.  Assessment of Medication Safety Using Only Dispensing Data.

Authors:  Nicole Pratt; Elizabeth Roughead
Journal:  Curr Epidemiol Rep       Date:  2018-09-28

9.  Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016.

Authors:  Benjamin Daniels; Sallie-Anne Pearson; Nicholas A Buckley; Claudia Bruno; Helga Zoega
Journal:  Therap Adv Gastroenterol       Date:  2020-03-19       Impact factor: 4.409

10.  Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program.

Authors:  Andre Q Andrade; Vanessa T LeBlanc; Lisa M Kalisch-Ellett; Nicole L Pratt; Anna Moffat; Natalie Blacker; Kerrie Westaway; John D Barratt; Elizabeth E Roughead
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.